This is not a good look:
https://www.nytimes.com/2024/10/23/s...mid=tw-nytimes
I will say that there are valid reasons to delay publishing studies (original study not sufficiently powered, recruiting more subjects, etc.), but at first blush this smells like advocacy. If that's the case, this can potentially undermine all the work she's done advocating for transgender patients.
I'd also stress we can't read too much into this. It may end up that adolescent transgender care needs revising. But policy decisions shouldn't be made on the sole basis of this study, whenever it gets published.
An influential doctor and advocate of adolescent gender treatments said she had not published a long-awaited study of puberty-blocking drugs because of the charged American political environment.
The doctor, Johanna Olson-Kennedy, began the study in 2015 as part of a broader, multimillion-dollar federal project on transgender youth. She and colleagues recruited 95 children from across the country and gave them puberty blockers, which stave off the permanent physical changes — like breasts or a deepening voice — that could exacerbate their gender distress, known as dysphoria.
The researchers followed the children for two years to see if the treatments improved their mental health. An older Dutch study had found that puberty blockers improved well-being, results that inspired clinics around the world to regularly prescribe the medications as part of what is now called gender-affirming care.
But the American trial did not find a similar trend, Dr. Olson-Kennedy said in a wide-ranging interview. Puberty blockers did not lead to mental health improvements, she said, most likely because the children were already doing well when the study began.
The doctor, Johanna Olson-Kennedy, began the study in 2015 as part of a broader, multimillion-dollar federal project on transgender youth. She and colleagues recruited 95 children from across the country and gave them puberty blockers, which stave off the permanent physical changes — like breasts or a deepening voice — that could exacerbate their gender distress, known as dysphoria.
The researchers followed the children for two years to see if the treatments improved their mental health. An older Dutch study had found that puberty blockers improved well-being, results that inspired clinics around the world to regularly prescribe the medications as part of what is now called gender-affirming care.
But the American trial did not find a similar trend, Dr. Olson-Kennedy said in a wide-ranging interview. Puberty blockers did not lead to mental health improvements, she said, most likely because the children were already doing well when the study began.
I will say that there are valid reasons to delay publishing studies (original study not sufficiently powered, recruiting more subjects, etc.), but at first blush this smells like advocacy. If that's the case, this can potentially undermine all the work she's done advocating for transgender patients.
I'd also stress we can't read too much into this. It may end up that adolescent transgender care needs revising. But policy decisions shouldn't be made on the sole basis of this study, whenever it gets published.
). Is loser men competing in women's sports the no. 1 issue facing Americans? Of course not. But the left couldn't leave it alone, and it kicked them in the balls.

Comment